[Ocular rosacea : Clinical aspects, diagnostics, management and treatment].

Louise Partzsch, Katrin Nguyen, Sören Korsing, Uwe Pleyer

Abstract readReviewEnglish Abstract

In one paragraph

Review in Die Ophthalmologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Louise PartzschAugenklinik Campus Virchow Klinikum - Universitätsmedizin Berlin Charité, Universitätsmedizin Berlin, Freie Universität Berlin und Humboldt-Universität zu Berlin, Berlin, Deutschland.

Katrin NguyenDermatologie Campus Virchow Klinikum, Universitätsmedizin Berlin Charité, Universitätsmedizin Berlin, Freie Universität Berlin und Humboldt-Universität zu Berlin, Berlin, Deutschland.

Sören KorsingDermatologie Campus Virchow Klinikum, Universitätsmedizin Berlin Charité, Universitätsmedizin Berlin, Freie Universität Berlin und Humboldt-Universität zu Berlin, Berlin, Deutschland.

Uwe PleyerAugenklinik Campus Virchow Klinikum - Universitätsmedizin Berlin Charité, Universitätsmedizin Berlin, Freie Universität Berlin und Humboldt-Universität zu Berlin, Berlin, Deutschland. uwe.pleyer@charite.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ocular rosacea is a chronic inflammatory disease that affects the surface of the eye and the eyelids. It often occurs in conjunction with rosacea in the facial area but can also occur independently. It is characterized by bilateral chronic posterior blepharitis and meibomitis, which can involve the entire surface of the eye, including the cornea, during the course of the disease. The diagnosis is largely based on clinical findings. The main symptoms include reddened, burning and itchy eyes, dryness, sensitivity to light and blurred vision. The exact etiology of ocular rosacea is not fully understood. A genetic predisposition, dysregulation of the immune system, environmental factors and microbial factors are involved. Treatment usually includes a combination of eyelid hygiene, topical and, if necessary, systemic agents. The prognosis is generally considered favorable; however, in the case of untreated ocular rosacea, severe progressive courses can also lead to blindness.

Indexed as

RosaceaBlepharitisCombined Modality TherapyDiagnosis, DifferentialHumansBlepharitisDry eyeEyelidMeibomian gland dysfunctionOcular surface disease

Identifiers

PMID40522449

DOI10.1007/s00347-025-02265-z

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.